Skip to Content

Disclaimer

Disclaimer
MDS makes every effort to publish accurate information on the website. "Google Translate" is provided as a free tool for visitors to read content in one's native language. Translations are not guaranteed to be 100% accurate. Neither MDS nor its employees assume liability for erroneous translations of website content.

Congress
Main Content

Plenary Session 4206

Disease-Modifying Trials for Parkinson’s Disease: Past, Present and Future

Wednesday, October 8, 2025
10:00 - 11:30 | Room TBD
Clinical

In this session, the faculty will discuss recent and ongoing disease modifying trials in Parkinson's disease. Challenges in clinical trial design and the way forward will be discussed.


Chairs:
Susan Fox, Canada
Nobutaka Hattori, Japan

Presenters:

Recent and Ongoing Trials
Tatyana Simuni, USA

Challenges in Patient Selection
Camille Carroll, United Kingdom

Challenges in Trial Design
Olivier Rascol, France

CSPC Liaisons:
Huw Morris, United Kingdom

Learning Objectives
At the conclusion of this session, participants should be better able to:

  1. Discuss recent and ongoing or in development trials for disease modification in Parkinson's disease
  2. Discuss challenges in patient selection including biomarkers and recruitment of prodromal subjects
  3. Discuss the importance of improving outcome measures including multi-arm multi-stage trial design, remote monitoring and digital technologies

Recommended Audience
Clinician / General Neurology
Fellow / Resident / Student
Health Professional (non-physician)
Industry
Researcher / Basic Science

Education Level
Advanced / Expert
Beginner / Foundational
Intermediate / Experienced

We use cookies to give you the best possible experience with our website. These cookies are also used to ensure we show you content that is relevant to you. If you continue without changing your settings, you are agreeing to our use of cookies to improve your user experience. You can click the cookie settings link on our website to change your cookie settings at any time. Note: The MDS site uses related multiple domains, including mds.movementdisorders.org and mds.execinc.com. This cookie policy only covers the primary movementdisorders.org and mdscongress.org domain. Please refer to the MDS Privacy Policy for information on how to configure cookies for all other domains on the MDS site.
Cookie PolicyPrivacy Notice